Servier Canada

Lixiana is a once-daily anticoagulant that is approved for stroke prevention in atrial fibrillation and for the prevention of recurrent deep-vein thrombosis and pulmonary embolism. Lancora is an If channel inhibitor indicated to reduce the incidence of cardiovascular death and hospitalization due to chronic heart failure.